Company Filing History:
Years Active: 2024
Title: The Innovations of Stuart Madden
Introduction
Stuart Madden is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental health disorders. His innovative approach has led to the development of a unique formulation that enhances the delivery of medication.
Latest Patents
Madden holds a patent for "Intranasal olanzapine formulations and methods of their use." This patent focuses on compositions for intranasal delivery of olanzapine, which is used to treat various symptoms of schizophrenia, schizoaffective disorder, and bipolar disorder. The formulation includes dodecyl maltoside to improve the bioavailability of olanzapine, allowing for administration via the nasal mucosa to avoid direct systemic administration. This innovative method aims to provide relief for acute agitation, mania, and mixed episodes.
Career Highlights
Stuart Madden is currently associated with Neurelis, Inc., where he continues to work on advancing treatments for mental health conditions. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, contributing to the development of effective therapies.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Stuart Madden's work in developing intranasal olanzapine formulations represents a significant advancement in the treatment of mental health disorders. His innovative contributions continue to impact the pharmaceutical landscape positively.